The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
10.27
-0.02 (-0.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
The Joint Employees
As of December 31, 2023, The Joint had 794 total employees, including 444 full-time and 350 part-time employees. The number of employees increased by 13 or 1.66% compared to the previous year.
Employees
794
Change (1Y)
13
Growth (1Y)
1.66%
Revenue / Employee
$152,136
Profits / Employee
-$21,229
Market Cap
153.88M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Adaptimmune Therapeutics | 449 |
Sutro Biopharma | 302 |
Metagenomi | 236 |
Seres Therapeutics | 233 |
Cellectis | 221 |
Biomea Fusion | 103 |
Nanobiotix | 102 |
Aligos Therapeutics | 66 |
JYNT News
- 25 days ago - The Joint Corp. to Participate in the 13th Annual ROTH Deer Valley Event - GlobeNewsWire
- 6 weeks ago - The Joint Corp. (JYNT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - The Joint Chiropractic is Named the Official Chiropractor of Grand Canyon University Athletics - PRNewsWire
- 2 months ago - The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results - GlobeNewsWire
- 2 months ago - The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer - GlobeNewsWire
- 2 months ago - The Joint Chiropractic Ranks No. 150 on the Franchise Times Top 400 - PRNewsWire
- 2 months ago - The Joint Chiropractic Celebrates 25 Years of Making Quality Chiropractic Care Accessible - PRNewsWire